Mario De Michele
Papers
6
Total Citations
103
H-Index
5
About
Mario De Michele is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes for prostate cancer patients, with a particular focus on robot-assisted radical prostatectomy (RARP). His major contributions lie in refining perioperative pain management and understanding the predictors of postoperative complications and hospital readmission. In a landmark double-blind randomized controlled trial (2018, 36 citations), he demonstrated that combining local anesthetic wound infiltration with ultrasound-guided transversus abdominis plane block significantly improves pain control and recovery after RARP. De Michele has also made critical contributions to risk stratification, showing that obesity strongly predicts clinically undetected lymph node metastases in intermediate- and high-risk patients (2020, 21 citations), and that extended pelvic lymph node dissection, open surgical approach, and seminal vesicle invasion are independent predictors of hospital readmission (2020, 11–19 citations). His work on ABO blood group as a potential marker for positive surgical margins (2021) further highlights his innovative approach to personalizing prostate cancer care. With a research portfolio that directly impacts clinical decision-making and patient recovery, De Michele is a key figure in advancing evidence-based, minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6